Aspirin/Ligustrazine phosphate

阿司匹林/磷酸川芎嗪

Report date: 2022/01/14 13:23:58

Base Information

Drug NameAspirin/Ligustrazine phosphate
Drug Alias NameLigustrazine phosphate/Aspirin磷酸川芎嗪阿司匹林Aspirin and Ligustrazine phosphate阿司匹林磷酸川芎嗪乙酰水杨酸/阿司匹林 +[12] 
ClassificationSmall molecules
Mechanisms of ActionCyclooxygenases inhibitors
TargetsCyclooxygenases
Therapy Area/IndicationsCerebral Infarction
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsYes Ligustrazine phosphateAspirin
Global Highest StatusDiscontinued (IND)
Highest Status in ChinaDiscontinued
Originator CompaniesShenyang Huatai Medication Research Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesShenyang Huatai Medication Research Co Ltd
Active IndicationsN/A
Inactive IndicationsCerebral Infarction

Other Information

ATC CodeN/A
Related LinksN/A